Answer
Basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma have been reported in patients taking Jakavi (ruxolitinib phosphate).
Sources for this answer
- Jakavi 5mg, 10mg, 15mg and 20mg TabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 29Document updated
Sources checked